FindTrial
Sign In

Clinical study on short- and long-term efficacy and influencing factors of focused ultrasound ablation for pancreatic cancer

Clinical study on short- and long-term efficacy and influencing factors of focused ultrasound ablation for pancreatic cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053590
Enrollment
Unknown
Registered
2021-11-24
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

case series:High intensity focused ultrasound ablation

Sponsors

Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed advanced pancreatic cancer; 2. ECOG score: = 2cm); 4. The main organ function is in the compensation period; 5. Meet the FUAS treatment technology adaptation standard; 6. Patients or their families agree to cooperate with this research.

Exclusion criteria

Exclusion criteria: 1. The patient cannot receive the complete treatment process and follow-up due to severe cognitive or consciousness disorders; 2. Due to the damage of vital organs such as the heart, liver and kidney, the researcher believes that it is not suitable to participate in this research; 3. The presence of relevant imaging contraindications prevents the evaluation of target lesions.

Design outcomes

Primary

MeasureTime frame
Ablation rate;Tumor volume;Overall survival;—

Secondary

MeasureTime frame
Visual analogue scale score;Nutritional status;Quality of life score;—

Countries

China

Contacts

Public ContactChen Wenzhi

Chongqing Medical University

chenwz@cqmu.edu.cn+86 13608335926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026